摘要
观察１８１例急性白血病患者（急非淋１２０例，急淋６１例）外周血幼红细胞出现情况，结果显示急非淋和急淋外周血幼红细胞出现率分别为３２．５０％和２８．８７％；急性白血病外周血幼红细胞出现与贫血程度无关；急非淋者外周血未出现幼红细胞者对治疗反应好，完全缓解率高，尤其在Ｍ４、Ｍ５亚型更为明显，生存期也较长，提示外周血幼红细胞出现与否可作为急非淋的疗效和预后评价的辅助指标。
Erythroblast in peripheral blood of 181 patients with acute Leukemia were observed, The results showed that 32. 50% patients in ANLL and 28. 8% patients in ALL had erythroblast in peripheral blood. There were no relation between erythroblast in peripheral blood in acute leukemia and anemia. In ANLL, the patients which hadn't erythroblast in peripheral blood had better response for treatment and higher complete remission rate, it is more obvious in M4 and M5 subtypes. The during of survival was also longer. It indicated that the observation of erythroblast in peripheral blood might be taken as a supplem entary indication in judgement the effect of treatment and prognosis in ANLL.
出处
《肿瘤防治研究》
CAS
CSCD
北大核心
1996年第6期332-334,共3页
Cancer Research on Prevention and Treatment
